Research and experimental development on natural sciences and engineering
ACD PHARMACEUTICALS AS
Revenue 2024
NOK 24.7m
Operating profit
NOK −3.8m
Equity
NOK 14.0m
Incorporated
1997
Employees
10
Share capital
NOK 10.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 24.7m | |
| Total operating costs | 28.5m | |
| Operating profit (EBIT) | −3.8m | |
| Net financial items | −717k | |
| Profit for the year | −967k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 75.4m | |
| of which current assets | 27.1m | |
| Equity | 14.0m | |
| Total liabilities | 61.5m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.